XML 43 R31.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Options (Tables)
12 Months Ended
Dec. 31, 2022
Stock Options  
Schedule of weighted average assumptions

For the Years Ended December 31, 

 

2022

2021

 

Weighted average fair value of options granted

    

$

2.67

    

$

3.73

Risk-free interest rate

 

1.94% - 4.09

%  

 

0.22% - 0.82

%

Expected life (years)

 

3-6.42

 

3-6

Expected volatility factor

 

62%-79

%  

 

58% - 68

%

Expected dividends

 

None

 

None

Schedule of stock-based compensation expense

The stock-based compensation expense related to the Company’s stock plans were allocated as follows (in thousands):

Year Ended December 31, 

    

2022

    

2021

Direct operating costs

$

214

$

178

Selling and adminstrative expenses

 

3,069

 

1,572

Total stock-based compensation

$

3,283

$

1,750

Equity Plans  
Stock Options  
Schedule of stock option activity

    

    

    

Weighted-Average

    

Weighted -Average

Remaining

Number of

Exercise

Contractual Term

Aggregate

Options

Price

(years)

Intrinsic Value

Outstanding at January 1, 2021

 

5,906,884

$

1.61

 

6.86

 

89,405

Granted

 

1,226,300

 

6.84

 

 

Exercised

 

(1,556,288)

 

2.01

 

 

Forfeited/Expired

 

(40,000)

 

1.41

 

 

Outstanding at December 31, 2021

5,536,896

$

2.66

7.52

$

19,154,463

Granted*

1,774,558

4.91

Exercised

(248,763)

1.34

Forfeited/Expired

(372,201)

6.55

Outstanding at December 31, 2022

 

6,690,490

$

3.09

 

7.19

$

5,989,709

Exercisable at December 31, 2022

 

4,124,775

$

1.96

 

6.10

$

5,533,056

Vested and Expected to Vest at December 31, 2022

 

6,690,490

$

3.09

 

7.19

$

5,989,709

Schedule of stock-based compensation expense

    

    

    

Weighted-

    

Weighted -

Average

Average

Remaining

Aggregate

Number of

Exercise

Contractual

Intrinsic

Options

Price

Term (years)

Value

Outstanding at January 1, 2021

 

-

$

-

 

-

 

-

Granted

 

-

 

-

 

  

 

  

Exercised

 

-

 

-

 

  

 

  

Forfeited/Expired

 

-

 

-

 

  

 

  

Outstanding at December 31, 2021

 

-

$

-

 

-

 

-

Granted*

 

1,030,000

 

3.46

 

  

 

  

Exercised

 

 

-

 

  

 

  

Forfeited/Expired

 

(2,500)

 

3.41

 

  

 

  

Outstanding at December 31, 2022

 

1,027,500

$

3.46

 

9.75

$

-

Exercisable at December 31, 2022

 

18,750

$

5.40

 

9.52

$

-

Vested and Expected to Vest at December 31, 2022

 

1,027,500

$

3.46

 

9.75

$

-

*During the year ended December 31, 2022, the Company granted 132,000 stock options to non-employee directors of the Company which vest on the first anniversary of the date of grant. In addition, during the year ended December 31, 2022 the Company granted 50,000 stock options to non-employee members of the Company’s advisory board in lieu of cash compensation. The stock options vest in 12 monthly installments from the date of grant.

Restricted Stock  
Stock Options  
Summary of restricted stock under the Company's Plan

    

Number of

    

Weighted-Average

Restricted Stock

Grant Date Fair

Awards

Value

Outstanding January 1, 2021

50,000

Granted

-

Vested

(25,000)

Unvested at December 31, 2021

25,000

$

1.38

Granted

-

Vested

 

(25,000)

 

1.38

Forfeited/Expired

 

-

 

Unvested at December 31, 2022

 

-

$

-

Restricted Stock Units  
Stock Options  
Summary of restricted stock under the Company's Plan

    

    

Weighted-

Number of

Average

Restricted Stock

Grant Date

Units

Fair Value

Outstanding January 1, 2021

 

-

 

  

Granted

 

-

 

  

Vested

 

-

 

  

Unvested at December 31, 2021

 

-

 

  

Granted*

 

700,000

$

5.59

Vested

 

-

 

  

Forfeited/Expired

 

-

 

  

Unvested at December 31, 2022

 

700,000

$

5.59

* 200,000 RSUs were issued under the 2013 Plan and 500,000 RSUs were issued under the 2021 Plan.